Last $4.67 USD
Change Today 0.00 / 0.00%
Volume 0.0
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 06/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank L. Karbe

Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 2 different industries.

See Board Relationships
43$1,368,968
As of Fiscal Year 2012

Background*

Mr. Frank L. Karbe has been the Chief Financial Officer and Executive Vice President of Exelixis Inc., since July 9, 2007 and January 2004 respectively and serves as its Principal Accounting Officer. Mr. Karbe served as Senior Vice President of Exelixis Inc. since January 2004. From 1997 to January 2004, he served as an Investment Banker for Goldman Sachs & Co., where he served as Vice President in the healthcare group focusing on corporate finance and mergers & acquisitions ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

2010-Present
Director and Chairman of Audit Committee

Education*

MBA
WHU - Otto Beisheim School of Management

Other Affiliations*

Annual Compensation*

Salary$438,249
Bonus$232,981
Total Annual Compensation$671,230

Stock Options*

Exercisable Options1,031,458
Exercisable Options Value$2,156
Unexercisable Options274,042
Unexercisable Options Value$94
Total Value of Options$2,250
Total Number of Options1,387,500

Total Compensation*

Total Annual Cash Compensation$671,230
Total Short Term Compensation$671,230
Total Calculated Compensation$1,368,968
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $4.67 USD --

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$193.6K
Daniel R. Passeri MSc., J.D.Chief Executive Officer and Director
Curis, Inc.
$601.9K
James S. J. Manuso Ph.D., MBAChairman of The Board and Chief Executive Officer
Astex Pharmaceuticals, Inc.
$1.3M
Werner Lanthaler MBA/MPAChief Executive Officer
Evotec AG
€714.0K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$536.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.